These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27941431)

  • 41. Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis.
    Gottlieb J; Mattner F; Weissbrodt H; Dierich M; Fuehner T; Strueber M; Simon A; Welte T
    Respir Med; 2009 May; 103(5):743-9. PubMed ID: 19117741
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early plasma soluble receptor for advanced glycation end-product levels are associated with bronchiolitis obliterans syndrome.
    Shah RJ; Bellamy SL; Lee JC; Cantu E; Diamond JM; Mangalmurti N; Kawut SM; Ware LB; Christie JD
    Am J Transplant; 2013 Mar; 13(3):754-9. PubMed ID: 23331756
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bronchiolitis obliterans syndrome development in lung transplantation patients.
    Parada MT; Alba A; Sepúlveda C
    Transplant Proc; 2010; 42(1):331-2. PubMed ID: 20172344
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ?
    Verleden SE; Ruttens D; Vandermeulen E; Vaneylen A; Dupont LJ; Van Raemdonck DE; Verleden GM; Vanaudenaerde BM; Vos R
    Transplantation; 2013 May; 95(9):1167-72. PubMed ID: 23425818
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bronchoalveolar Lavage-microRNAs Are Potential Novel Biomarkers of Outcome After Lung Transplantation.
    Palleschi A; Gaudioso G; Edefonti V; Musso V; Terrasi A; Ambrogi F; Franzi S; Rosso L; Tarsia P; Morlacchi LC; Ferrero S; Nosotti M; Vaira V
    Transplant Direct; 2020 May; 6(5):e547. PubMed ID: 32548241
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circulating microRNAs as novel biomarkers for dilated cardiomyopathy.
    Wang H; Chen F; Tong J; Li Y; Cai J; Wang Y; Li P; Hao Y; Tian W; Lv Y; Chong J; Yang J
    Cardiol J; 2017; 24(1):65-73. PubMed ID: 27748501
    [TBL] [Abstract][Full Text] [Related]  

  • 47. VEGF synthesis and VEGF receptor 2 expression in patients with bronchiolitis obliterans syndrome after lung transplantation.
    Larsson-Callerfelt AK; Müller C; Andersson-Sjöland A; Thiman L; Larsson H; Hallgren O; Bjermer L; Eriksson L; Westergren-Thorsson G
    Respir Med; 2020 May; 166():105944. PubMed ID: 32250877
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circulating miR-150, miR-192, miR-200b, and miR-423-3p as Non-invasive Biomarkers of Chronic Allograft Dysfunction.
    Zununi Vahed S; Poursadegh Zonouzi A; Mahmoodpoor F; Samadi N; Ardalan M; Omidi Y
    Arch Med Res; 2017 Jan; 48(1):96-104. PubMed ID: 28577875
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lack of association between beta-herpesvirus infection and bronchiolitis obliterans syndrome in lung transplant recipients in the era of antiviral prophylaxis.
    Manuel O; Kumar D; Moussa G; Chen MH; Pilewski J; McCurry KR; Studer SM; Crespo M; Husain S; Humar A
    Transplantation; 2009 Mar; 87(5):719-25. PubMed ID: 19295317
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circulating exosomes with lung self-antigens as a biomarker for chronic lung allograft dysfunction: A retrospective analysis.
    Sharma M; Gunasekaran M; Ravichandran R; Fisher CE; Limaye AP; Hu C; McDyer J; Kaza V; Bharat A; Tokman S; Omar A; Arjuna A; Walia R; Bremner RM; Smith MA; Hachem RR; Mohanakumar T
    J Heart Lung Transplant; 2020 Nov; 39(11):1210-1219. PubMed ID: 32713614
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of miR-142-5p in peripheral blood mononuclear cells from renal transplant patients with chronic antibody-mediated rejection.
    Danger R; Paul C; Giral M; Lavault A; Foucher Y; Degauque N; Pallier A; Durand M; Castagnet S; Duong Van Huyen JP; Delahousse M; Renaudin K; Soulillou JP; Brouard S
    PLoS One; 2013; 8(4):e60702. PubMed ID: 23577151
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome.
    Valentine VG; Gupta MR; Walker JE; Seoane L; Bonvillain RW; Lombard GA; Weill D; Dhillon GS
    J Heart Lung Transplant; 2009 Feb; 28(2):163-9. PubMed ID: 19201342
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Humoral immunity in phenotypes of chronic lung allograft dysfunction: A broncho-alveolar lavage fluid analysis.
    Vandermeulen E; Verleden SE; Bellon H; Ruttens D; Lammertyn E; Claes S; Vandooren J; Ugarte-Berzal E; Schols D; Emonds MP; Van Raemdonck DE; Opdenakker G; Verleden GM; Vos R; Vanaudenaerde BM
    Transpl Immunol; 2016 Sep; 38():27-32. PubMed ID: 27561239
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome?
    Moffatt-Bruce SD; Karamichalis J; Robbins RC; Whyte RI; Theodore J; Reitz BA
    Ann Thorac Surg; 2006 Jan; 81(1):286-91; discussion 291. PubMed ID: 16368382
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnostic value of serum miR-144-3p for the detection of acute cellular rejection in heart transplant patients.
    Pérez-Carrillo L; Sánchez-Lázaro I; Triviño JC; Feijóo-Bandín S; Lago F; González-Juanatey JR; Martínez-Dolz L; Portolés M; Tarazón E; Roselló-Lletí E
    J Heart Lung Transplant; 2022 Feb; 41(2):137-147. PubMed ID: 34895840
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pre-transplant soluble CD30 is associated with bronchiolitis obliterans syndrome after lung transplantation.
    Bauwens AM; van de Graaf EA; van Ginkel WG; van Kessel DA; Otten HG
    J Heart Lung Transplant; 2006 Apr; 25(4):416-9. PubMed ID: 16563971
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The potential role of microRNAs in lung allograft rejection.
    Ladak SS; Ward C; Ali S
    J Heart Lung Transplant; 2016 May; 35(5):550-9. PubMed ID: 27197771
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of risk factors for the development of bronchiolitis obliterans syndrome.
    Husain AN; Siddiqui MT; Holmes EW; Chandrasekhar AJ; McCabe M; Radvany R; Garrity ER
    Am J Respir Crit Care Med; 1999 Mar; 159(3):829-33. PubMed ID: 10051258
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pretransplant serum human chitinase-like glycoprotein YKL-40 concentrations independently predict bronchiolitis obliterans development in lung transplant recipients.
    Jaksch P; Taghavi S; Klepetko W; Salama M
    J Thorac Cardiovasc Surg; 2014 Jul; 148(1):273-81. PubMed ID: 24685381
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of T Cell-Mediated Vascular Rejection After Kidney Transplantation by the Combined Measurement of 5 Specific MicroRNAs in Blood.
    Matz M; Fabritius K; Lorkowski C; Dürr M; Gaedeke J; Durek P; Grün JR; Goestemeyer A; Bachmann F; Wu K; Rudolph B; Schmidt D; Weber U; Haftmann C; Unterwalder N; Lachmann N; Radbruch A; Neumayer HH; Mashreghi MF; Budde K
    Transplantation; 2016 Apr; 100(4):898-907. PubMed ID: 26444957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.